1. Home
  2. PECO vs TVTX Comparison

PECO vs TVTX Comparison

Compare PECO & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phillips Edison & Company Inc.

PECO

Phillips Edison & Company Inc.

N/A

Current Price

$38.84

Market Cap

5.0B

Sector

Real Estate

ML Signal

N/A

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

N/A

Current Price

$50.41

Market Cap

4.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PECO
TVTX
Founded
1991
N/A
Country
United States
United States
Employees
320
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
4.7B
IPO Year
2010
2013

Fundamental Metrics

Financial Performance
Metric
PECO
TVTX
Price
$38.84
$50.41
Analyst Decision
Buy
Strong Buy
Analyst Count
14
15
Target Price
$43.00
★ $75.21
AVG Volume (30 Days)
1.3M
★ 1.8M
Earning Date
10-26-2026
11-02-2026
Dividend Yield
★ 3.57%
N/A
EPS Growth
74.51
★ 92.89
EPS
★ 1.05
N/A
Revenue
★ $726,594,000.00
N/A
Revenue This Year
$4.26
$47.49
Revenue Next Year
$6.62
$48.73
P/E Ratio
$36.84
★ N/A
Revenue Growth
★ 9.86
N/A
52 Week Low
$33.10
$22.59
52 Week High
$44.38
$68.73

Technical Indicators

Market Signals
Indicator
PECO
TVTX
Relative Strength Index (RSI) 58.21 35.14
Support Level $38.78 $49.46
Resistance Level $40.49 $59.93
Average True Range (ATR) 0.73 2.20
MACD 0.14 0.21
Stochastic Oscillator 85.16 16.43

Price Performance

Historical Comparison
PECO
TVTX

About PECO Phillips Edison & Company Inc.

Phillips Edison & Co Inc is a real estate investment trust. The company also operates a third-party investment management business providing property management and advisory services to four unconsolidated institutional joint ventures, in which it has a partial ownership interest, and one private fund. It invests in well-occupied, grocery-anchored neighborhood and community shopping centers. It holds an integrated in-house operating platform built on a market of expertise designed to optimize property value and consistently deliver a great shopping experience.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: